This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Oxford Nanopore Technologies
Oxford Nanopore Technologies, a pioneering company in the field of genomics, is headquartered in the United Kingdom. Founded in 2005, the company has rapidly established itself as a leader in the biotechnology industry, focusing on innovative DNA and RNA sequencing technologies. With a commitment to making genomic information accessible, Oxford Nanopore offers unique products such as the MinION, a portable sequencer that enables real-time analysis of genetic material. This groundbreaking technology distinguishes itself through its scalability and versatility, catering to a wide range of applications from academic research to clinical diagnostics. Recognised for its significant contributions to the field, Oxford Nanopore has achieved notable milestones, including the first real-time sequencing of a human genome. The company continues to expand its global presence, driving advancements in genomics and empowering researchers worldwide.
DitchCarbon Score
How does Oxford Nanopore Technologies's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Oxford Nanopore Technologies's score of 79 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Oxford Nanopore Technologies's reported carbon emissions
In 2024, Oxford Nanopore Technologies reported total greenhouse gas emissions of approximately 51,215,000 kg CO2e across all scopes. This includes 313,000 kg CO2e from Scope 1, 1,210,000 kg CO2e from Scope 2, and a significant 51,215,000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming for a 42% reduction in absolute Scope 1 and 2 emissions by 2030, based on a 2023 baseline. Additionally, they target a 52% reduction in Scope 3 emissions per GBP value added within the same timeframe. Long-term goals include achieving net-zero greenhouse gas emissions across the entire value chain by 2045, with a target of at least a 90% reduction in Scope 1, 2, and 3 emissions by the same year. These targets are aligned with the Science Based Targets initiative (SBTi) and are classified as consistent with the reductions required to limit global warming to 1.5°C. The emissions data and reduction targets are solely from Oxford Nanopore Technologies, with no cascaded data from parent organizations. The company is committed to transparency and accountability in its climate strategy, reflecting its dedication to sustainability within the biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 359,200 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 1,091,700 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Oxford Nanopore Technologies is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
